We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARI
2326
Apollo Commercial Real Estate
ARI
$886M
$51K ﹤0.01%
4,805
-9,700
-67% -$106K
CNTA
2327
DELISTED
Centessa Pharmaceuticals
CNTA
$51K ﹤0.01%
16,171
+10,894
+206% +$40.4K
CSTM icon
2328
Constellium
CSTM
$3.95B
$51K ﹤0.01%
4,317
-9,669
-69% -$113K
CWEN icon
2329
Clearway Energy Class C
CWEN
$7.02B
$51K ﹤0.01%
1,623
-19,416
-92% -$654K
FMNB icon
2330
Farmers National Banc Corp
FMNB
$970M
$51K ﹤0.01%
3,610
-2,886
-44% -$40.7K
HBNC icon
2331
Horizon Bancorp
HBNC
$1.05B
$51K ﹤0.01%
3,388
-2,289
-40% -$37.8K
IVE icon
2332
iShares S&P 500 Value ETF
IVE
$50.3B
$51K ﹤0.01%
351
+65
+23% +$9.28K
JETS icon
2333
US Global Jets ETF
JETS
$832M
$51K ﹤0.01%
2,975
-14,213
-83% -$248K
MNRO icon
2334
Monro
MNRO
$352M
$51K ﹤0.01%
1,121
-2,302
-67% -$106K
RNAC icon
2335
Cartesian Therapeutics
RNAC
$264M
$51K ﹤0.01%
1,510
-577
-28% -$24.5K
SKE
2336
Skeena Resources
SKE
$4.07B
$51K ﹤0.01%
9,631
-260
-3% -$1.32K
SNN icon
2337
Smith & Nephew
SNN
$12.6B
$51K ﹤0.01%
1,917
-709
-27% -$17.8K
SPRX icon
2338
Spear Alpha ETF
SPRX
$240M
$51K ﹤0.01%
4,295
-18,974
-82% -$243K
UVSP icon
2339
Univest Financial
UVSP
$1.19B
$51K ﹤0.01%
1,941
-10,555
-84% -$283K
WOR icon
2340
Worthington Enterprises
WOR
$2.85B
$51K ﹤0.01%
1,674
-14,797
-90% -$458K
ZNTL icon
2341
Zentalis Pharmaceuticals
ZNTL
$297M
$51K ﹤0.01%
2,578
-3,443
-57% -$74K
RCM
2342
DELISTED
R1 RCM Inc. Common Stock
RCM
$51K ﹤0.01%
4,641
-37,884
-89% -$481K
AAIC
2343
DELISTED
Arlington Asset Investment Corp.
AAIC
$51K ﹤0.01%
17,394
-5,307
-23% -$15.7K
ACWX icon
2344
iShares MSCI ACWI ex US ETF
ACWX
$12B
$50K ﹤0.01%
1,092
-1,100
-50% -$48.2K
AGM icon
2345
Federal Agricultural Mortgage
AGM
$2.51B
$50K ﹤0.01%
439
-632
-59% -$72.7K
BBIO icon
2346
BridgeBio Pharma
BBIO
$15.9B
$50K ﹤0.01%
6,484
-10,311
-61% -$98.7K
BBU
2347
DELISTED
Brookfield Business Partners
BBU
$50K ﹤0.01%
2,949
+1,574
+114% +$30.5K
BCSF icon
2348
Bain Capital Specialty
BCSF
$821M
$50K ﹤0.01%
4,218
+1,605
+61% +$20.4K
CTBI icon
2349
Community Trust Bancorp
CTBI
$1.44B
$50K ﹤0.01%
1,099
-3,294
-75% -$150K
FA icon
2350
First Advantage
FA
$3.81B
$50K ﹤0.01%
3,847
-1,397
-27% -$18.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.